Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has shared an update.
ASKA Pharmaceutical Holdings Co., Ltd. has received a statement of intent from Dalton Investments and associated entities to potentially purchase up to 30% of the company’s shares. This move could lead to proposals aimed at enhancing corporate value and shareholder interests, with the possibility of delisting the company if deemed beneficial. The company’s board plans to review the terms of this large-scale purchase and will provide necessary information to shareholders for consideration.
The most recent analyst rating on (JP:4886) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on ASKA Pharmaceutical Holdings Co., Ltd. stock, see the JP:4886 Stock Forecast page.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates within the pharmaceutical industry, focusing on the development and distribution of medical products. The company is headquartered in Minato-ku, Tokyo, and is listed on the Tokyo Stock Exchange under the ticker 4886.
Average Trading Volume: 37,884
Technical Sentiment Signal: Buy
Current Market Cap: Yen61.45B
Find detailed analytics on 4886 stock on TipRanks’ Stock Analysis page.